Diabetes

Common osteoporosis drug may reduce risk of type 2 diabetes

New research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD), held online this year, suggests that the widely used osteoporosis drug alendronate reduces the risk of type ...

Medications

Romosozumab substantially builds bone density in hip and spine

New research presented at ACR Convergence, the American College Rheumatology's annual meeting, reveals that romosozumab, an osteoporosis drug, produces substantial gains in bone mineral density in the hip and lumbar spine ...

Diseases, Conditions, Syndromes

What's the right age to test for osteoporosis?

(HealthDay)—Osteoporosis is a threat to many women, especially after menopause. But the lead up to weak, brittle bones can start much earlier in life.

page 1 from 6